145 related articles for article (PubMed ID: 10223941)
1. Pharmacokinetics of rifapentine in subjects seropositive for the human immunodeficiency virus: a phase I study.
Keung AC; Owens RC; Eller MG; Weir SJ; Nicolau DP; Nightingale CH
Antimicrob Agents Chemother; 1999 May; 43(5):1230-3. PubMed ID: 10223941
[TBL] [Abstract][Full Text] [Related]
2. Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers.
Dooley KE; Savic RM; Park JG; Cramer Y; Hafner R; Hogg E; Janik J; Marzinke MA; Patterson K; Benson CA; Hovind L; Dorman SE; Haas DW;
Antimicrob Agents Chemother; 2015; 59(6):3399-405. PubMed ID: 25824215
[TBL] [Abstract][Full Text] [Related]
3. Single-dose pharmacokinetics of rifapentine in elderly men.
Keung AC; Eller MG; Weir SJ
Pharm Res; 1998 Aug; 15(8):1286-91. PubMed ID: 9706063
[TBL] [Abstract][Full Text] [Related]
4. Single and multiple dose pharmacokinetics of rifapentine in man: part II.
Keung A; Eller MG; McKenzie KA; Weir SJ
Int J Tuberc Lung Dis; 1999 May; 3(5):437-44. PubMed ID: 10331734
[TBL] [Abstract][Full Text] [Related]
5. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
Vernon A; Burman W; Benator D; Khan A; Bozeman L
Lancet; 1999 May; 353(9167):1843-7. PubMed ID: 10359410
[TBL] [Abstract][Full Text] [Related]
6. Enzyme induction observed in healthy volunteers after repeated administration of rifapentine and its lack of effect on steady-state rifapentine pharmacokinetics: part I.
Keung A; Reith K; Eller MG; McKenzie KA; Cheng L; Weir SJ
Int J Tuberc Lung Dis; 1999 May; 3(5):426-36. PubMed ID: 10331733
[TBL] [Abstract][Full Text] [Related]
7. Effects of four different meal types on the population pharmacokinetics of single-dose rifapentine in healthy male volunteers.
Zvada SP; Van Der Walt JS; Smith PJ; Fourie PB; Roscigno G; Mitchison D; Simonsson US; McIlleron HM
Antimicrob Agents Chemother; 2010 Aug; 54(8):3390-4. PubMed ID: 20516273
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers.
Weiner M; Egelund EF; Engle M; Kiser M; Prihoda TJ; Gelfond JA; Mac Kenzie W; Peloquin CA
J Antimicrob Chemother; 2014 Apr; 69(4):1079-85. PubMed ID: 24343893
[TBL] [Abstract][Full Text] [Related]
9. Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial.
Dooley KE; Savic R; Gupte A; Marzinke MA; Zhang N; Edward VA; Wolf L; Sebe M; Likoti M; Fyvie MJ; Shibambo I; Beattie T; Chaisson RE; Churchyard GJ;
Lancet HIV; 2020 Jun; 7(6):e401-e409. PubMed ID: 32240629
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of rifapentine in patients with varying degrees of hepatic dysfunction.
Keung AC; Eller MG; Weir SJ
J Clin Pharmacol; 1998 Jun; 38(6):517-24. PubMed ID: 9650541
[TBL] [Abstract][Full Text] [Related]
11. Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations.
Dooley K; Flexner C; Hackman J; Peloquin CA; Nuermberger E; Chaisson RE; Dorman SE
Antimicrob Agents Chemother; 2008 Nov; 52(11):4037-42. PubMed ID: 18765687
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy.
Weiner M; Bock N; Peloquin CA; Burman WJ; Khan A; Vernon A; Zhao Z; Weis S; Sterling TR; Hayden K; Goldberg S;
Am J Respir Crit Care Med; 2004 Jun; 169(11):1191-7. PubMed ID: 14962821
[TBL] [Abstract][Full Text] [Related]
13. New regimens to prevent tuberculosis in adults with HIV infection.
Martinson NA; Barnes GL; Moulton LH; Msandiwa R; Hausler H; Ram M; McIntyre JA; Gray GE; Chaisson RE
N Engl J Med; 2011 Jul; 365(1):11-20. PubMed ID: 21732833
[TBL] [Abstract][Full Text] [Related]
14. One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis.
Swindells S; Ramchandani R; Gupta A; Benson CA; Leon-Cruz J; Mwelase N; Jean Juste MA; Lama JR; Valencia J; Omoz-Oarhe A; Supparatpinyo K; Masheto G; Mohapi L; da Silva Escada RO; Mawlana S; Banda P; Severe P; Hakim J; Kanyama C; Langat D; Moran L; Andersen J; Fletcher CV; Nuermberger E; Chaisson RE;
N Engl J Med; 2019 Mar; 380(11):1001-1011. PubMed ID: 30865794
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of rifapentine in children.
Blake MJ; Abdel-Rahman SM; Jacobs RF; Lowery NK; Sterling TR; Kearns GL
Pediatr Infect Dis J; 2006 May; 25(5):405-9. PubMed ID: 16645503
[TBL] [Abstract][Full Text] [Related]
16. A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine.
Francis J; Zvada SP; Denti P; Hatherill M; Charalambous S; Mungofa S; Dawson R; Dorman S; Gupte N; Wiesner L; Jindani A; Harrison TS; Olagunju A; Egan D; Owen A; McIlleron HM
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670438
[TBL] [Abstract][Full Text] [Related]
17. Potent twice-weekly rifapentine-containing regimens in murine tuberculosis.
Rosenthal IM; Williams K; Tyagi S; Peloquin CA; Vernon AA; Bishai WR; Grosset JH; Nuermberger EL
Am J Respir Crit Care Med; 2006 Jul; 174(1):94-101. PubMed ID: 16574936
[TBL] [Abstract][Full Text] [Related]
18. Single-dose pharmacokinetics of rifapentine in women.
Keung AC; Eller MG; Weir SJ
J Pharmacokinet Biopharm; 1998 Feb; 26(1):75-85. PubMed ID: 9773393
[TBL] [Abstract][Full Text] [Related]
19. Rifapentine pharmacokinetics in adolescents.
Marshall JD; Abdel-Rahman S; Johnson K; Kauffman RE; Kearns GL
Pediatr Infect Dis J; 1999 Oct; 18(10):882-8. PubMed ID: 10530584
[TBL] [Abstract][Full Text] [Related]
20. Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention.
Podany AT; Bao Y; Swindells S; Chaisson RE; Andersen JW; Mwelase T; Supparatpinyo K; Mohapi L; Gupta A; Benson CA; Kim P; Fletcher CV;
Clin Infect Dis; 2015 Oct; 61(8):1322-7. PubMed ID: 26082504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
